Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 16,427 | 18,839 | 23,033 | 16,910 | 18,464 |
| Cost of Goods | 1,202 | 836 | 2,061 | 1,371 | 851 |
| Gross Profit | 15,225 | 18,003 | 20,972 | 15,539 | 17,613 |
| Operating Expenses | 46,396 | 62,986 | 49,497 | 48,346 | 54,028 |
| Operating Income | -30,969 | -44,147 | -28,464 | -32,436 | -35,564 |
| Interest Expense | 13,392 | 12,997 | 12,230 | 11,919 | 13,117 |
| Other Income | 3,395 | 1,752 | 2,257 | 13,307 | 4,802 |
| Pre-tax Income | -40,966 | -55,392 | -38,437 | -31,048 | -43,879 |
| Income Tax | N/A | 1,254 | 165 | -321 | 90 |
| Net Income Continuous | -40,966 | -56,646 | -38,602 | -30,727 | -43,969 |
| Net Income | $-40,966 | $-56,646 | $-38,602 | $-30,727 | $-43,969 |
| EPS Basic Total Ops | -0.30 | -0.50 | -0.36 | -0.26 | -0.42 |
| EPS Basic Continuous Ops | -0.30 | -0.50 | -0.36 | -0.26 | -0.42 |
| EPS Diluted Total Ops | -0.30 | -0.50 | -0.36 | -0.26 | -0.42 |
| EPS Diluted Continuous Ops | -0.30 | -0.50 | -0.36 | -0.26 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.50 | -0.36 | -0.29 | -0.42 |
| EBITDA(a) | $-30,847 | $-43,307 | $-27,663 | $-31,643 | $-34,762 |